E. Furmaniakkazmierczak et al., STUDIES OF THROMBIN-INDUCED PROTEOGLYCAN RELEASE IN THE DEGRADATION OF HUMAN AND BOVINE CARTILAGE, The Journal of clinical investigation, 94(2), 1994, pp. 472-480
Because fibrin is commonly observed within arthritic joints, studies m
ere undertaken to determine whether purified coagulation and fibrinoly
tic proteases degrade cartilage in vitro and to seek evidence for the
activation of coagulation in arthritic joints through measurements of
the levels of inhibitor-enzmye complexes and several other proteins as
sociated with coagulation and fibrinolysis. The concentrations of 13 p
lasma proteins and complexes of thrombin and Factor Xa with antithromb
in III were measured in synovial fluids recovered at the time of knee
replacement surgery. All zymogens necessary to constitute the coagulat
ion cascade were present. Thrombin and the combination of prothrombin
plus prothrombinase induced proteoglycan release from both normal and
arthritic cartilages. Factor Xa and plasmin induced release from disea
sed cartilage only, and urokinase, tissue plasminogen activator, and a
ctivated protein C were without effect at the levels used. At saturati
ng levels of thrombin (greater than or equal to 2.0 mu M) 80% of the p
roteoglycan content of normal cartilage was released within 24 h. Thro
mbin, which is cationic, reversibly binds cartilage with K-d = 7.0 +/-
1.0 mu M and B-max = 820 +/- 70 ng/mg of human cartilage. Levels of t
hrombin-antithrombin III complexes in synovial fluids and arthritis we
re 4-fold higher in osteo(OA) and 43-fold higher in rheumatoid(RA) tha
n in controls (0.98 nM). Factor Xa-antithrombin m complex levels were
threefold lower in OA and fivefold higher in KA than in controls (0.24
nM). These elevated levels of enzyme-inhihitor complexes imply a hist
ory of activation of coagulation within the joint, especially in IU. S
ince thrombin degrades cartilage in vitro and had been generated in vi
vo, as inferred by the existence of thrombin-antithrombin III complexe
s, intraarticular activation of coagulation may both contribute to the
pathology of arthritis and comprise a target for therapy and diagnosi
s.